Table II.
Parameter | Unexposed(n = 45)a | Exposed(n = 80)a | P for exposed versus unexposedb | ||||
Urinary markers | AM | GM | GSD | AM | GM | GSD | |
Creatinine [mmol L−1] | 11.6 | 10.3 | 1.72 | 13.7 | 11.6 | 1.86 | 0.27 |
VEGF [ng l−1]c | 302.7 | 210.6 | 2.15 | 257.0 | 210.4 | 1.91 | 0.99 |
AlphaGST [µg l−1] | 8.1 | 6.1 | 2.20 | 8.3 | 6.1 | 2.35 | 0.98 |
PiGST [µg l−1] | 26.5 | 18.2 | 2.78 | 31.2 | 23.9 | 2.15 | 0.09 |
KIM-1 [ng l−1] | 211.7 | 162.7 | 2.19 | 311.2 | 254.1 | 1.87 | 0.01 |
NAG [units l−1] | 2.5 | 1.8 | 2.49 | 2.6 | 1.8 | 3.06 | 0.94 |
aAM, arithmetic mean; GM, Geometric mean; GSD, Geometric standard deviation
b t-Test of difference in mean between ln(urinary marker) between unexposed and exposed individuals.
cSamples of one control and three exposed subjects were not analysed for VEGF.